FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097933 [Registered on: 24/11/2025] Trial Registered Prospectively
Last Modified On: 22/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Yoga & Naturopathy
Diagnostic 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing yoga therapy and usual medical treatment to see which helps women with PCOS ovulate better 
Scientific Title of Study   Comparison of Yoga-Integrated Therapy and Standard Medical Management on Ovulation Outcomes in Women with Polycystic Ovary Syndrome: A Randomised Control Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sommya Naberia 
Designation  POST GRADUATE RESIDENT,Obs & Gynae department 
Affiliation  Lady Hardinge Medical College 
Address  Obs & gynae department ,Gynae office,ground floor purani building,near hospital kitchen
Lady Hardinge Medical College Connaught Place
New Delhi
DELHI
110001
India 
Phone  6264889011  
Fax    
Email  sommyayaya@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pikee Saxena 
Designation  Director Professor,Head of Unit 
Affiliation  GYNAECOLOGY OPD AND INFERTILITY OPD LADY HARDINGE MEDICAL COLLEGE 
Address  Obs&Gynae department, room no 413 4th floor old building Near Hospital kitchen
Lady Hardinge Medical College Connaught Place
New Delhi
DELHI
110001
India 
Phone  09868223323  
Fax    
Email  pikeesaxena@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Meenakshi Singh 
Designation  Professor 
Affiliation  Lady Hardinge Medical College 
Address  Obs& Gynae department 3rd floor Porta Cabin Old Building near hospital kitchen
Lady Hardinge Medical College Connaught Place New Delhi
New Delhi
DELHI
110001
India 
Phone  9560511155  
Fax    
Email  drmeenakshisingh99@gmail.com  
 
Source of Monetary or Material Support  
nil  
 
Primary Sponsor  
Name  Dr Sommya Naberia 
Address  Obs&Gynae department gynae office ground floor near hospital kitchen Purani building Lady Hardinge Medical College Connaught Place New Delhi pincode 110001  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sommya Naberia  Lady Hardinge Medical College  Department of Obstetrics and gynaecology Infertility OPD , Room 120 Connaught place
New Delhi
DELHI 
9205755665

sommyayaya@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Ethics Committee for Human Research Lady Hardinge Medical College and Associated Hospitals  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E282||Polycystic ovarian syndrome,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Standard medical management for infertile women with PCOS  GROUP-B: Control group 50 Infertile Females with PCOS will be advised lifestyle management for a period of 6weeks and then will be started with ovulation induction by letrozole for 3 months alongside lifestyle advice for 12 weeks 
Intervention  Yoga Integrated Therapy for infertile women with PCOS   Group-A INTERVENTION GROUP 50 Infertile Females with PCOS will be exposed to Yoga Therapy for 6 weeks followed by standard medical treatment alongside yoga therapy for 3months. During the first 6 weeks the subjects will practice Yoga regularly for 5 days a week. During the next 12 weeks i.e. the 3months period subjects will practice Yoga twice a week on Mondays and Thursdays in OPD and for remaining days at home & will be given ovulation induction by letrozole for 3 months for the same duration. Participants will be monitored on weekly basis through the phone & videos calls and by maintaining a separate participant diary for keeping a track of no. of sessions attended. Session length – 45-50min Home sessions monitored by video calls under supervision of yoga therapists on remaining days of the week  
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  38.00 Year(s)
Gender  Female 
Details  Infertile women aged between 19 and 38 years & diagnosed with PCOS as per Rotterdam Criteria
Willingness and ability to participate in the structured yoga intervention program for the entire study
duration.
Possession of a smartphone with internet access for regular follow-up reminders and compliance
monitoring
Willingness to comply with study procedures, including regular attendance at yoga sessions and follow up visits 
 
ExclusionCriteria 
Details  Known cases of chronic systemic illnesses, such as cerebrovascular diseases, thyroid disorders
cardiovascular diseases, or any other severe systemic illness & physical disorders that would interfere with
study participation or compliance
Presence of tubal factor and/or male factor infertility and poor ovarian reserve
Women who have received ovulation induction drugs within the last three months prior to recruitment
History of recurrent pregnancy loss, defined as two or more consecutive spontaneous miscarriages
Prior regular practice of structured physical exercise programs, example regular workouts or yoga or
meditation within the last six months 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
PRIMARY OUTCOME:
OUTCOME VARIABLES:
Proportion of infertile women with PCOS who ovulate in two groups receiving structured yoga plus standard
treatment versus standard treatment alone using TVUS follicular monitoring and Day-21 Progesterone levels 
At baseline and after 12weeks period 
 
Secondary Outcome  
Outcome  TimePoints 
Menstrual Cycle changes
Cardiometabolic parameter changes
hormone profile changes
mental health & quality of life parameters changes 
At baseline & after 12weeks 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   03/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="30" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) - 

  6. For how long will this data be available start date provided 10-11-2026 and end date provided 06-12-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Polycystic ovarian syndrome being an endocrine disorder is the most common cause for infertility in reproductive age females  While pharmacological therapies for PCOS primarily focus on ovulation induction they often fall short in addressing the broader metabolic and emotional needs  YIT offers a holistic alternative that targets these multifaceted concerns Evidence suggests that yoga can improve insulin sensitivity regulate hormonal imbalances reduce stress improve cardiometabolic outcomes and enhance overall wellbeing factors that are directly implicated in the pathology of PCOS  There is a paucity of data evaluating yoga as an adjunct therapy to improve ovulation rates in infertile women with PCOS while also addressing metabolic, hormonal, and psychological health in infertile Indian women. This study aims to fill that gap by assessing the effectiveness of structured yoga intervention alongside standard treatment providing a cost effective holistic approach for improving ovulation rates in Indian infertile females with PCOS 
Close